Comparing the efficacy of hemodialysis with super high-flux dialyzer between first use and repeated use

Phase 2

Recruiting

• Conditions: ESRD on regular hemodialysis; Dialyzer reuse, Super high-flux dialyzer, High-performance membrane, Hemodialysis, Middle molecule uremic toxin, Beta-2 microglobulin, Total cell volume, fiber bundle volume

• Registration Number: TCTR20211209004
• Lead Sponsor: The Kidney Foundation of Thailand

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2021-12-09
• Study Completion: 2021-12-31
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 15

Inclusion Criteria

1. ESRD on regular HD 2 with spKt/V more than 1.8 or HD 3 time/wk with spKt/V more than 1.2
2. RRF less than 100 ml/day, 3. Vascular access AVF or AVG, 4. Hemodynamic stability

Exclusion Criteria

1. Active CVD, 2. Active malignancy, 3. Pregnancy, 4. Decompensated cirrhosis, 5. Malnutrition, 6. Patient preference

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
remic toxin 4 months Uremic toxin clearance

Secondary Outcome Measures

Name	Time	Method
Dilaysate albumin 4 months gram of dialysate albumin